<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alexander, Lori</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Libby, Peter</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Inflammatory Biomarkers Update: Overview of Recent Research</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">32-32</style></pages><abstract><style  face="normal" font="default" size="100%">The sequence of events that leads to atherosclerosis and plaque rupture remains a fruitful area of cardiology research. There is growing evidence that there is heterogeneity in monocytes that plays a role in the inflammatory pathways of disease. Monocytes contribute to the atherosclerotic process as precursors of foam cells in the atherosclerotic plaque. This article discusses recent developments in inflammation research and gives an update on lipoprotein-associated phospholipase A2 and its role as a marker of inflammation.</style></abstract><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">7</style></volume></record></records></xml>